ADARx Pharmaceuticals, Inc. · NASDAQ:ADRX
ORBIMED ADVISORS LLC reported a 14.00% stake in ADARx Pharmaceuticals, Inc. (Schedule 13D)
Event Sep 28, 2026 · Filed Oct 2, 2026
ORBIMED ADVISORS LLC reported a 14.00% stake in ADARx Pharmaceuticals, Inc., 14,913,764 shares, with active intent on Sep 28, 2026. Filed Oct 2, 2026 (Schedule 13D).
- Stake
- 14.00%
- Shares
- 14,913,764
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 14.00% | 14,913,764 |
| ORBIMED CAPITAL GP VII LLC | 13.40% | 14,325,529 |
| ORBIMED ADVISORS ISRAEL II LTD | 8.70% | 9,292,025 |
| ORBIMED ISRAEL GP II, L.P. | 8.70% | 9,292,025 |
| OrbiMed Genesis GP LLC | 0.60% | 588,235 |
Source
Related
- ADARx Pharmaceuticals, Inc.
- Orbimed Advisors LLC
- ADARx Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Zhen Li · Nov 16, 2026
- Schedule 13G · Zhen Li · Nov 13, 2026
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026